Here are four key notes:
1. Two analysts gave the shares a “buy” rating.
2. Eleven analysts rated the shares “neutral.”
3. No analysts rated the sells a “sell” or “strong sell.”
4. Last month, Berenberg Bank reiterated Smith & Nephew’s “buy” rating.
More articles on devices:
Dr. Kenneth Zaslav performs Virginia’s first meniscus replacement using NUsurface Implant — 4 highlights
Midwest Orthopaedic Institute offers new technology for back pain treatment: 4 insights
Orthofix upgraded to ‘strong buy’ rating — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
